Clark, D.R.Omer, S.B.Tapia, M.D.Nunes, M.C.Cutland, C.L.Tielsch, J.M.Wairagkar, N.Madhi, S.A.BMGF Supported Maternal Influenza Immunization Trials Investigators Group2024-03-222024-03-222020-07Clark DR, Omer SB, Tapia MD, Nunes MC, Cutland CL, Tielsch JM, Wairagkar N, Madhi SA; for BMGF Supported Maternal Influenza Immunization Trials Investigators Group. Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials. Pediatr Infect Dis J. 2020 Jul;39(7):641-644. doi: 10.1097/INF.0000000000002629.10.1097/INF.0000000000002629https://pubmed.ncbi.nlm.nih.gov/32379201/https://hdl.handle.net/11288/595625This analysis includes pooled data from 2 placebo-controlled maternal influenza immunization trials, with a separate analysis on a meningococcal conjugate vaccine-controlled maternal influenza immunization trial. Maternal influenza immunization was not associated with infant or maternal all-cause mortality in placebo-controlled trials. In the meningococcal conjugate vaccine-controlled trial, there were fewer deaths during low or any influenza circulation weeks among infants whose mothers received meningococcal conjugate vaccine. ClinicalTrials.gov identifiers: NCT01430689, NCT01034254 and NCT02465190.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Maternal immunizationMeningococcalInfluenzaVaccineRandomized controlled trialSDG-03 Good health and well-beingInfluenza or meningococcal immunization during pregnancy and mortality in women and infantsArticleThe Pediatric Infectious Diseases Journal